Blood Ropivacaine Concentrations Following Chest Wall Nerve Block Continuous Infusion

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Pain, Postoperative

Interventions

DRUG

Ropivacaine infusion

Delivered via paravertebral nerve block catheter.

Trial Locations (1)

"Boston ChildrenS Hospital", Boston

All Listed Sponsors

lead

Boston Children's Hospital

OTHER

NCT02860091 - Blood Ropivacaine Concentrations Following Chest Wall Nerve Block Continuous Infusion | Biotech Hunter | Biotech Hunter